1988
DOI: 10.1159/000184909
|View full text |Cite
|
Sign up to set email alerts
|

Parameters of the Kallikrein-Kinin, Coagulation and Fibrinolytic Systems as Early Indicators of Kidney Transplant Rejection

Abstract: In order to find early indicators of kidney transplant rejection before clinical symptoms were noticed, parameters of the coagulation, fibrinolytic and kallikrein-kinin systems were measured. Nineteen patients were followed before and daily after kidney transplantation during the first week and every second day in the following weeks. All patients received immunosuppressive therapy with ciclosporin and corticoids. Ten patients suffered from transplant rejection. The first rejection occurred on the 7th day afte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
3
0

Year Published

1989
1989
2012
2012

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 8 publications
2
3
0
Order By: Relevance
“…No significant changes in plasma kallikrein-Cl-inhibitor complex levels were observed, suggesting that activation of coagulation did not occur via the intrinsic pathway and thus probably was mediated via the extrinsic pathway of coagulation. Pre-treatment values of plasma TATc, t-PA and PAPc levels in all patients were slightly elevated as compared to healthy controls, which is probably due to the acute rejection process of the renal allograft, as was described by Schrader et al (25). In clinical trials performed on side effects (1,26) and in our own experience, treatment with OKT3 at a dose of 5 mg/day is not associated with thromboembolic complications, which may be explained by the relatively short duration of coagulation activation and simulta neous activation of fibrinolysis.…”
Section: Discussionsupporting
confidence: 66%
“…No significant changes in plasma kallikrein-Cl-inhibitor complex levels were observed, suggesting that activation of coagulation did not occur via the intrinsic pathway and thus probably was mediated via the extrinsic pathway of coagulation. Pre-treatment values of plasma TATc, t-PA and PAPc levels in all patients were slightly elevated as compared to healthy controls, which is probably due to the acute rejection process of the renal allograft, as was described by Schrader et al (25). In clinical trials performed on side effects (1,26) and in our own experience, treatment with OKT3 at a dose of 5 mg/day is not associated with thromboembolic complications, which may be explained by the relatively short duration of coagulation activation and simulta neous activation of fibrinolysis.…”
Section: Discussionsupporting
confidence: 66%
“…Furthermore, the important role of the liver in hemostasis has been illustrated by the correction of inherited coagulation defects by OLT [lo, 191. Previous studies have also indicated that parameters of the coagulation system are of importance as predictive indicators of kidney transplant rejection [29]. Our studies have revealed the following variations in levels of some components of the kallikrein-kinin, coagulation, and fibrinolytic systems, which lead us to believe that activation of these systems occurs not only during OLT but also during the period following OLT 1.…”
Section: Discussionsupporting
confidence: 62%
“…35 Elevated levels have been reported in conjunction with pregnancy, 36 hormonal contraceptives, 37 obesity, 38 anabolic steroids, 39 hypothyroidism, 40 and in liver or kidney transplant patients. 41 In this study, no significant change in plasminogen activity was noted for either GnRH-a treated or control groups. α2-Antiplasmin is the fast SERPIN inhibitor of plasmin.…”
Section: Discussionmentioning
confidence: 48%